Eton Pharmaceuticals (ETON) Income towards Parent Company (2018 - 2026)
Eton Pharmaceuticals (ETON) posted Income towards Parent Company of $1.7 million for Q4 2025, up 188.01% sequentially from -$1.9 million in Q3 2025, and up 383.61% YoY from $350694.3 in Q4 2024.
Eton Pharmaceuticals (ETON) Income towards Parent Company (2018 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Income towards Parent Company for 8 years, with the latest figure at $1.7 million in Q4 2025.
- Quarterly Income towards Parent Company rose 383.61% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.4 million (down 14.78% YoY) and the FY2025 annual result came in at -$4.4 million, down 14.78% from the prior year.
- Income towards Parent Company grew to $1.7 million in Q4 2025 per ETON's latest filing, from -$1.9 million in the prior quarter.
- Over five years, Income towards Parent Company peaked at $5.1 million in Q1 2021 and troughed at -$6.1 million in Q3 2021.
- A 5-year average of -$891850.0 and a median of -$1.6 million in 2022 frame the typical range for Income towards Parent Company.
- The sharpest annual moves came in 2023 and 2025: Income towards Parent Company soared 392.62% in 2023, then tumbled 407.34% in 2025.
- Over 5 years, Income towards Parent Company stood at $1.0 million in 2021, then jumped by 170.07% to $2.8 million in 2022, then plunged by 166.43% to -$1.9 million in 2023, then soared by 67.92% to -$598000.0 in 2024, then surged by 383.61% to $1.7 million in 2025.
- According to Business Quant data, Income towards Parent Company over the past three periods registered $1.7 million, -$1.9 million, and -$2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Eton Pharmaceuticals | 1.69 Bn | 1.66 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.58 Mn |
| Dec 31, 2025 | 1.70 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -2.59 Mn |
| Mar 31, 2025 | -1.57 Mn |
| Dec 31, 2024 | -598,000.00 |
| Sep 30, 2024 | 627,000.00 |
| Jun 30, 2024 | -3.04 Mn |
| Mar 31, 2024 | -811,000.00 |
| Dec 31, 2023 | -1.86 Mn |
| Sep 30, 2023 | -579,000.00 |
| Jun 30, 2023 | 4.56 Mn |
| Mar 31, 2023 | -2.66 Mn |
| Dec 31, 2022 | 2.81 Mn |
| Sep 30, 2022 | -3.05 Mn |
| Jun 30, 2022 | -1.56 Mn |
| Mar 31, 2022 | -5.33 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | -6.09 Mn |
| Jun 30, 2021 | -2.02 Mn |